metastatic prostate cancer

You have access
Evaluation of ¹⁷⁷Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective ¹⁷⁷Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)
Sarennya Pathmanandavel, Megan Crumbaker, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Adam Hickey, Peter Eu, Martin Stockler, Andrew J. Martin, Anthony M. Joshua, Andrew Nguyen and Louise Emmett

Journal of Nuclear Medicine February 1, 2023, 64 (2) 221-226; DOI: https://doi.org/10.2967/jnumed.122.264398
You have access
The Prognostic Value of Posttreatment ⁶⁸Ga-PSMA-11 PET/CT and ¹⁸F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with ¹⁷⁷Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN)
Sarennya Pathmanandavel, Megan Crumbaker, Andrew Nguyen, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Peter Eu, Andrew J. Martin, Martin R. Stockler, Anthony M. Joshua and Louise Emmett

Journal of Nuclear Medicine January 1, 2023, 64 (1) 69-74; DOI: https://doi.org/10.2967/jnumed.122.264104
You have access
The prognostic role of ⁶⁸Ga-PSMA11 PET-based response in prostate cancer patients undergoing taxane-based chemotherapy
Lukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, Isabel Rauscher, Calogero D'Alessandria, Benedikt Feuerecker, Thomas Langbein, Robert Tauber, Stefan Schiele, Wolfgang Andreas Weber and Matthias Eiber

Journal of Nuclear Medicine December 29, 2022, jnumed.122.264962; DOI: https://doi.org/10.2967/jnumed.122.264962
You have access
¹⁷⁷Lu-PSMA SPECT Quantitation at 6 Weeks (dose 2) Predicts Short Progression Free Survival for Patients Undergoing Lu PSMA I&T Therapy.
Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker, William Counter, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Aron Poole, Adam Hickey, Shikha Agrawal, Gary Perkins, Annukka Kallinen, Enid Eslick, Martin R. Stockler, Anthony M. Joshua, Andrew Nguyen and Louise Emmett

Journal of Nuclear Medicine September 8, 2022, jnumed.122.264677; DOI: https://doi.org/10.2967/jnumed.122.264677
You have access
¹⁷⁷Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial
Sarennya Pathmanandavel, Megan Crumbaker, Andrew O. Yam, Andrew Nguyen, Christopher Rofe, Elizabeth Hovey, Craig Gedye, Edmond M. Kwan, Christine Hauser, Arun A. Azad, Peter Eu, Andrew J. Martin, Anthony M. Joshua and Louise Emmett

Journal of Nuclear Medicine April 1, 2022, 63 (4) 560-566; DOI: https://doi.org/10.2967/jnumed.121.262552
You have access
Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with ¹⁸F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven Larson, Howard I. Scher and Hebert Alberto Vargas

Journal of Nuclear Medicine August 1, 2021, 62 (8) 1050-1056; DOI: https://doi.org/10.2967/jnumed.120.256602
You have access
A Prospective Comparison of ¹⁸F-Sodium Fluoride PET/CT and PSMA-Targeted ¹⁸F-DCFBC PET/CT in Metastatic Prostate Cancer
Stephanie A. Harmon, Ethan Bergvall, Esther Mena, Joanna H. Shih, Stephen Adler, Yolanda McKinney, Sherif Mehralivand, Deborah E. Citrin, Anna Couvillon, Ravi A. Madan, James L. Gulley, Ronnie C. Mease, Paula M. Jacobs, Martin G. Pomper, Baris Turkbey, Peter L. Choyke and M. Liza Lindenberg

Journal of Nuclear Medicine November 1, 2018, 59 (11) 1665-1671; DOI: https://doi.org/10.2967/jnumed.117.207373
You have access
A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition
Aseem Anand, Michael J. Morris, Reza Kaboteh, Mariana Reza, Elin Trägårdh, Naofumi Matsunaga, Lars Edenbrandt, Anders Bjartell, Steven M. Larson and David Minarik

Journal of Nuclear Medicine December 1, 2016, 57 (12) 1865-1871; DOI: https://doi.org/10.2967/jnumed.116.177030
You have access
Repeatability of Quantitative ¹⁸F-NaF PET: A Multicenter Study
Christie Lin, Tyler Bradshaw, Timothy Perk, Stephanie Harmon, Jens Eickhoff, Ngoneh Jallow, Peter L. Choyke, William L. Dahut, Steven Larson, John Laurence Humm, Scott Perlman, Andrea B. Apolo, Michael J. Morris, Glenn Liu and Robert Jeraj

Journal of Nuclear Medicine December 1, 2016, 57 (12) 1872-1879; DOI: https://doi.org/10.2967/jnumed.116.177295
You have access
Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer
Aseem Anand, Michael J. Morris, Reza Kaboteh, Lena Båth, May Sadik, Peter Gjertsson, Milan Lomsky, Lars Edenbrandt, David Minarik and Anders Bjartell

Journal of Nuclear Medicine January 1, 2016, 57 (1) 41-45; DOI: https://doi.org/10.2967/jnumed.115.160085

Main menu

User menu

Search

metastatic prostate cancer

Pages